Princeton Portfolio Strategies Group LLC Continues to Hold Holdings in Henry Schein, Inc. (HSIC)
Princeton Portfolio Strategies Group LLC held its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,515 shares of the company’s stock at the close of the second quarter. Princeton Portfolio Strategies Group LLC’s holdings in Henry Schein were worth $1,924,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Henry Schein by 3.0% during the second quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock worth $1,479,959,000 after buying an additional 236,862 shares during the period. FMR LLC boosted its position in shares of Henry Schein by 0.4% during the second quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after buying an additional 24,935 shares during the period. BlackRock Inc. boosted its position in shares of Henry Schein by 1.8% during the second quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after buying an additional 101,406 shares during the period. State Street Corp boosted its position in shares of Henry Schein by 1.3% during the first quarter. State Street Corp now owns 3,675,674 shares of the company’s stock worth $624,760,000 after buying an additional 48,469 shares during the period. Finally, Mackenzie Financial Corp boosted its position in shares of Henry Schein by 4.7% during the first quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock worth $293,747,000 after buying an additional 76,794 shares during the period. Institutional investors and hedge funds own 44.52% of the company’s stock.
Several equities analysts have recently issued reports on HSIC shares. Piper Jaffray Companies started coverage on Henry Schein in a research report on Monday, June 12th. They set a “neutral” rating and a $100.00 price objective for the company. Stifel Nicolaus reiterated a “hold” rating on shares of Henry Schein in a research report on Thursday, July 6th. Credit Suisse Group reiterated a “hold” rating and set a $80.00 price objective on shares of Henry Schein in a research report on Thursday, July 13th. Jefferies Group LLC reiterated a “hold” rating and set a $88.50 price objective on shares of Henry Schein in a research report on Friday, July 21st. Finally, BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and seven have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $92.17.
COPYRIGHT VIOLATION NOTICE: “Princeton Portfolio Strategies Group LLC Continues to Hold Holdings in Henry Schein, Inc. (HSIC)” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/08/princeton-portfolio-strategies-group-llc-continues-to-hold-holdings-in-henry-schein-inc-hsic.html.
In other news, SVP Paul Rose sold 2,126 shares of the stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the sale, the senior vice president now directly owns 17,841 shares of the company’s stock, valued at $3,077,750.91. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.27% of the stock is owned by corporate insiders.
Shares of Henry Schein, Inc. (HSIC) traded down 0.72% during midday trading on Friday, reaching $80.99. The company had a trading volume of 1,075,227 shares. The firm’s 50 day moving average price is $83.51 and its 200-day moving average price is $87.53. The company has a market capitalization of $12.81 billion, a P/E ratio of 23.67 and a beta of 1.08. Henry Schein, Inc. has a 12 month low of $73.11 and a 12 month high of $93.50.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. During the same period in the prior year, the firm earned $0.82 earnings per share. Henry Schein’s revenue was up 6.4% compared to the same quarter last year. Analysts anticipate that Henry Schein, Inc. will post $3.64 earnings per share for the current fiscal year.
Henry Schein declared that its Board of Directors has initiated a share repurchase plan on Monday, September 18th that allows the company to repurchase $400.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 6.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s board believes its shares are undervalued.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.